Viral DMPA content exaggerates risk and fuels fear
Summary
Since a 2024 study linked DMPA use with a small increase in meningioma risk, influencers and class-action attorneys have amplified the concern online. Many of these videos distort the data, fueling disproportionate fear about an already rare outcome. One viral example starts with alarm about “brain tumors from birth control” and then pivots into a grab bag of other contraceptive myths—an increasingly common pattern. While all medications carry potential risks, the current wave of DMPA content misrepresents the evidence and dramatically overstates the absolute risk of meningiomas.
